Literature DB >> 17401044

Hypothalamic-pituitary-adrenal axis response in borderline personality disorder without post-traumatic features.

Jose L Carrasco1, Marina Díaz-Marsá, Jose I Pastrana, Rosa Molina, Loreto Brotons, María I López-Ibor, Juan J López-Ibor.   

Abstract

Hypothalamic-pituitary-adrenal (HPA) axis sensitivity was investigated in 32 non-medicated patients with borderline personality disorder without comorbid post-traumatic syndromes and in 18 normal individuals using a modified dexamethasone suppression test (0.25 mg). Enhanced cortisol suppression was found in the patients v. controls (P<0.05) and the percentage of participant's with non-suppression was smaller in the patient (34%) than in the control group (89%) (P<0.01). Baseline cortisol levels in the patients were also lower than in the controls (P<0.05). The 0.25 mg dexamethasone suppression test reveals increased feedback inhibition of the HPA in borderline personality disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401044     DOI: 10.1192/bjp.bp.106.022590

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  9 in total

1.  Personality disorders and traits as predictors of incident cardiovascular disease: findings from the 23-year follow-up of the Baltimore ECA study.

Authors:  Hochang Benjamin Lee; O Joseph Bienvenu; Seong-Jin Cho; Christine M Ramsey; Karen Bandeen-Roche; William W Eaton; Gerald Nestadt
Journal:  Psychosomatics       Date:  2010 Jul-Aug       Impact factor: 2.386

2.  Borderline personality disorder: current drug treatments and future prospects.

Authors:  Bayanne Olabi; Jeremy Hall
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

3.  Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters.

Authors:  Barbara Stanley; Leo Sher; Scott Wilson; Rolf Ekman; Yung-yu Huang; J John Mann
Journal:  J Affect Disord       Date:  2009-11-25       Impact factor: 4.839

4.  Multimodal assessment of emotional reactivity in borderline personality pathology: the moderating role of posttraumatic stress disorder symptoms.

Authors:  Katherine L Dixon-Gordon; Kim L Gratz; Matthew T Tull
Journal:  Compr Psychiatry       Date:  2013-02-01       Impact factor: 3.735

5.  Cognitive modulation of endocrine responses to CRH stimulation in healthy subjects.

Authors:  James L Abelson; Samir Khan; Elizabeth A Young; Israel Liberzon
Journal:  Psychoneuroendocrinology       Date:  2009-09-16       Impact factor: 4.905

6.  The Neurobiological Basis of Adolescent-onset Borderline Personality Disorder.

Authors:  Marianne Goodman; Kathryn Mascitelli; Joseph Triebwasser
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-08

7.  Borderline personality disorder, trauma, and the hypothalamus-pituitary-adrenal axis.

Authors:  Natalie Thomas; Caroline Gurvich; Jayashri Kulkarni
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-09       Impact factor: 2.570

8.  Unmet challenges in treating hypertension in patients with borderline personality disorder: A systematic review.

Authors:  Saara M Roininen; Marcus Cheetham; Beatrice U Mueller; Edouard Battegay
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

9.  Reduced glucocorticoid receptor expression in blood mononuclear cells of patients with borderline personality disorder.

Authors:  José Manuel López-Villatoro; Karina S MacDowell; Marina Diaz-Marsá; Alejandro De La Torre-Luque; Clara Prittwitz; Alejandra Galvez-Merlin; Juan C Leza; Jose L Carrasco
Journal:  Front Psychiatry       Date:  2022-08-02       Impact factor: 5.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.